Obtainment of the spray-dried extracts of Peperomia pellucida L. (H.B.K.) using different atomization temperatures: physicochemical characterization and technological development for pharmaceutical applications
Authors (first, second and last of 14)
As an international journal, DARU Journal of Pharmaceutical Sciences considers outstanding studies from basic research to clinical investigations as original articles, systematic reviews, meta-analyses, general reviews, mini-reviews, short communications, and editorials from the global scientific community. Therefore, the journal welcomes submissions from all over the world.
- Considers outstanding studies from basic research to clinical investigations
- Indexed in Medline, Scopus, PubMed, Science Citaion Index
- No Article Processing charges
Journal information
- Editor-in-Chief
-
- Mohammad Abdollahi
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 2.739 (2019)
- Impact factor
- 3.027 (2019)
- Five year impact factor
- 23 days
- Submission to first decision
- 162 days
- Submission to acceptance
- 160,397 (2020)
- Downloads
Latest issue
Latest articles
-
-
Preventive effect of Rumex crispus L. on surgically induced intra-abdominal adhesion model in rats
Authors (first, second and last of 5)
-
HPLC methods for choloroquine determination in biological samples and pharmaceutical products
Authors
-
Surging trends in prescriptions and costs of antidepressants in England amid COVID-19
Authors (first, second and last of 5)
-
Comparing the cost, glycaemic control and medication adherence of utilizing patients’ own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting
Authors (first, second and last of 8)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Follow us on Twitter
DARU Journal of Pharmaceutical Sciences (@DaruSci) is on Twitter. Follow us and keep up to date with the latest journal news, research highlights, and more.
-
Follow us on LinkedIn
DARU Journal of Pharmaceutical Sciences is on LinkedIn.
About this journal
- Electronic ISSN
- 2008-2231
- Abstracted and indexed in
-
- BIOSIS
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Dimensions
- EBSCO Academic Search
- EBSCO Belt and Road Initiative Reference Source
- EBSCO Biomedical Reference Collection
- EBSCO CINAHL
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Gale
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Middle East & Africa Database
- ProQuest Research Library
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
